Key facts
- Notable investors include Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NIPOKA
- ·The full record, as it builds
Funding rounds
No funding rounds for NIPOKA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NIPOKA
Developer of three-dimensional reconstruction software intended for the quantification of podocyte foot process morphology. The company's platform uses a fluorescence microscopy-based imaging workflow combined with computational reconstruction to generate three-dimensional representations of podocyte ultrastructure, supporting segmentation, measurement, and comparison of morphological parameters, enabling biomedical and nephrology researchers to analyze structural changes in podocytes with reproducible, quantitative methods for research and experimental evaluation.
- Sector
- Healthcare
- HQ
- Greifswald, Germany
- Founded
- 2019
- Employees
- 2
- Website
- nipoka.com/
- Ownership
- Privately Held (backing)
NIPOKA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NIPOKA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NIPOKA in its N-PORT filings yet. We sweep new filings monthly.